An Adherence Tool to Manage Narcotic -Addicted HIV Patients

• Status: Completed
• Trial end date: 2014-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to develop a cost-effective breath-based medication adherence monitoring system that can monitor whether recovering opiate addicts actually take a specific treatment medication called naltrexone.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Xhale Assurance
• Collaborator: National Institute on Drug Abuse (NIDA)
• Treatments: Naltrexone; Narcotics

Criteria

Inclusion Criteria:

• Ability to understand and provide written informed consent

• Subject is at least 18 Years of Age

• Subject must be willing to comply with study procedures

Exclusion Criteria:

• <18 years

• Subject has a history of opioid use disorder

• current chronic opioid therapy or recent (past week) acute opioid therapy,

• currently pregnant

• contraindications to naltrexone use per FDA label.